Nonetheless, only three kinds of antidiabetic agents (glucagon-like peptide analogues [38], metformin [28, 39] and sodium-glucose cotransporter-2 inhibitors [40] have proven benefits in preventing T2D and its complications. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.